- Home
- SABS vs ALUR Comparison
SABS vs ALUR Comparison
Compare SABS & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- ALUR
- Stock Information
- Founded
- SABS 2014
- ALUR 2009
- Country
- SABS United States
- ALUR United States
- Employees
- SABS N/A
- ALUR N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- ALUR
- Sector
- SABS Health Care
- ALUR
- Exchange
- SABS Nasdaq
- ALUR Nasdaq
- Market Cap
- SABS 15.8M
- ALUR 18.0M
- IPO Year
- SABS N/A
- ALUR N/A
- Fundamental
- Price
- SABS $2.64
- ALUR $2.87
- Analyst Decision
- SABS Strong Buy
- ALUR Strong Buy
- Analyst Count
- SABS 5
- ALUR 3
- Target Price
- SABS $11.80
- ALUR $22.83
- AVG Volume (30 Days)
- SABS 35.3K
- ALUR 189.2K
- Earning Date
- SABS 08-07-2025
- ALUR 08-12-2025
- Dividend Yield
- SABS N/A
- ALUR N/A
- EPS Growth
- SABS N/A
- ALUR N/A
- EPS
- SABS N/A
- ALUR N/A
- Revenue
- SABS $377,835.00
- ALUR $28,304,000.00
- Revenue This Year
- SABS N/A
- ALUR N/A
- Revenue Next Year
- SABS N/A
- ALUR $49.37
- P/E Ratio
- SABS N/A
- ALUR N/A
- Revenue Growth
- SABS N/A
- ALUR N/A
- 52 Week Low
- SABS $1.00
- ALUR $2.15
- 52 Week High
- SABS $5.01
- ALUR $26.75
- Technical
- Relative Strength Index (RSI)
- SABS 77.22
- ALUR 66.83
- Support Level
- SABS $1.72
- ALUR $2.45
- Resistance Level
- SABS $2.72
- ALUR $2.59
- Average True Range (ATR)
- SABS 0.19
- ALUR 0.16
- MACD
- SABS 0.10
- ALUR 0.06
- Stochastic Oscillator
- SABS 91.89
- ALUR 78.57
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.